SAN FRANCISCO (June 21, 2018) – In his new role, Mr. Masoudi will be responsible for the Company’s global legal strategy and will report to JUUL’s Chief Executive Officer (CEO) Kevin Burns. Mr. Masoudi will be based in the Company’s Washington, D.C. office.
Since 2015, Mr. Masoudi has served as Executive Vice President, General Counsel and Corporate Secretary of Celgene Corporation. He previously served as Chief Counsel (2007-09) and Principal Deputy/Acting Chief Counsel (2004-05) of the U.S. Food and Drug Administration (FDA). In those roles, Mr. Masoudi supervised agency litigation and advised the FDA’s senior leadership on regulatory and enforcement matters.
“Jerry is a renowned legal expert in FDA regulation and life sciences, and I am honored to welcome him to the JUUL Labs team,” said Mr. Burns. “JUUL Labs is incredibly fortunate to benefit from his knowledge and experience as we work with the medical community, public health officials, regulators and community leaders to address the tremendous potential of e-cigarettes.”
“I am thrilled to join JUUL Labs and contribute to the Company’s important mission to eliminate combustible cigarette smoking,” said Mr. Masoudi. “I believe vapor technology has great promise, and I look forward to collaborating with key stakeholders to provide an alternative for adult smokers around the world.”
In addition to his time working for the FDA, from 2009-15 Mr. Masoudi was a partner and co-chair of the food and drug practice at the Washington, D.C. office of Covington & Burling LLP, where he advised FDA-regulated companies on a wide range of regulatory and litigation matters. Mr. Masoudi also served as Deputy Assistant Attorney General in the Antitrust Division of the U.S. Department of Justice, where he was responsible for international, policy and appellate matters. Mr. Masoudi also practiced for a decade as a litigator at Kirkland & Ellis LLP and Bartlit Beck Herman Palenchar & Scott.
Mr. Masoudi earned a B.A. in economics from Amherst College in 1990 and a J.D. with High Honors from the University of Chicago Law School in 1993.
About JUUL Labs
JUUL Labs is a technology company dedicated to eliminating cigarettes by offering existing adult smokers a true alternative to combustible cigarettes. The company’s research shows that more than one million smokers have already switched to JUUL, and we are working to enable millions more to switch in the coming years through technological innovations.
Media Contact: press@juul.com
October 2, 2024
On September 26th, Juul Labs’ Chairman & Chief Executive Officer, K.C. Crosthwaite, delivered the keynote address at the 2024 Global Tobacco & Nicotine Forum,…
July 29, 2024
Juul Labs announced today the settlement with a group of noteholders that confirms the conversion of the convertible notes to equity, and provides an…
June 6, 2024
Today, the FDA rescinded its June 2022 Marketing Denial Orders (MDOs) for the JUUL System and placed our applications back into scientific review. We appreciate the FDA’s decision and now look forward to re-engaging with the agency on a science- and evidence-based process to pursue a marketing authorization for JUUL products.